Tag
This review synthesizes evidence demonstrating that continuous glucose monitoring (CGM) metrics, particularly time above 140 mg/dL, predict progression to stage 3 type 1 diabetes with accuracy comparable to oral glucose tolerance test (OGTT
Acromegaly is often diagnosed late because symptoms are subtle. Serum IGF-I is the best screening test, OGTT confirms GH excess, and MRI localizes pituitary tumors. New AI and imaging tools may improve earlier detection.
A randomized controlled trial demonstrates that performing oral glucose tolerance tests before hospital discharge significantly improves screening rates and patient satisfaction compared to standard outpatient care for women with gestationa
This review analyzes the DIP randomized controlled trial, demonstrating that inpatient postpartum glucose testing achieves a 92.3% completion rate compared to 26.9% in outpatient settings, significantly improving detection of prediabetes an
A longitudinal study of 2,260 participants confirms that oral glucose tolerance test (OGTT)-based surrogate indexes, particularly Gutt and Cederholm, are superior to fasting-only measures in predicting type 2 diabetes, providing high clinic
